Equities

Spire Healthcare Group PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Spire Healthcare Group PLC

Actions
  • Price (EUR)2.30
  • Today's Change0.000 / 0.00%
  • Shares traded800.00
  • 1 Year change-17.86%
  • Beta1.2830
Data delayed at least 15 minutes, as of Feb 06 2026 07:38 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Spire Healthcare Group plc is an independent healthcare company. It operates approximately 38 hospitals and over 53 clinics, medical centers and consulting rooms across England, Wales and Scotland. It provides diagnostics, inpatient, day case and outpatient care in areas including orthopedics, gynecology, cardiology, neurology, oncology and general surgery. It also operates a network of private general practitioners (GPs), delivers private, National Health Service (NHS) and corporate mental health, dermatological and musculoskeletal services, and provides occupational health services to over 800 corporate clients. It also delivers a range of private and NHS mental health, musculoskeletal and dermatological services under the Vita Health Group brand. Its treatments include back surgery, breast enlargement, cataract removal surgery, gastric bypass surgery, hip replacement surgery, knee replacement, and prostate surgery. It also provides inpatient and outpatient physiotherapy services.

  • Revenue in GBP (TTM)1.55bn
  • Net income in GBP13.20m
  • Incorporated2014
  • Employees17.60k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SPI:LSE since
announced
Transaction
value
Physiolistic LtdDeal completed31 Jul 202531 Jul 2025Deal completed-9.33%6.88m
Acorn Occupational Health LtdDeal completed01 Apr 202501 Apr 2025Deal completed14.99%4.26m
Data delayed at least 20 minutes, as of Feb 06 2026 15:19 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.